• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15922 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2009 NIHR Horizon Scanning Centre (NIHR HSC) Fluocinolone acetonide intravitreal insert (Iluvien) for diabetic macular oedema
2009 NIHR Horizon Scanning Centre (NIHR HSC) Denufosol for cystic fibrosis with mild lung disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) BIBF 1120 for advanced and/or metastatic non-small cell lung cancer - second line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for advanced metastatic ovarian cancer
2009 NIHR Horizon Scanning Centre (NIHR HSC) Belimumab (Benlysta) for active systemic lupus erythematosus
2009 NIHR Horizon Scanning Centre (NIHR HSC) Alvocidib (Flavopiridol) for refractory/relapsed chronic lymphocytic leukaemia
2009 NIHR Horizon Scanning Centre (NIHR HSC) Adalimumab (Humira) for children with Crohn's disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Transcranial direct current stimulation (tDCS) for major depressive disorder
2009 NIHR Horizon Scanning Centre (NIHR HSC) Transcranial direct current stimulation (tDCS) for Alzheimer's disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Sativex for spasticity in multiple sclerosis
2009 NIHR Horizon Scanning Centre (NIHR HSC) Eslicarbazepine acetate for partial onset epilepsy - refractory
2009 NIHR Horizon Scanning Centre (NIHR HSC) Aripiprazole (Abilify) for major depressive disorder
2009 NIHR Horizon Scanning Centre (NIHR HSC) High dose fulvestrant (Faslodex) for locally advanced or metastatic breast cancer
2009 NIHR Horizon Scanning Centre (NIHR HSC) Bivalirudin (Angiox) for acute myocardial infarction with persistent ST-segment elevation treated by primary percutaneous coronary intervention
2009 NIHR Horizon Scanning Centre (NIHR HSC) Velaglucerase alfa for type 1 Gaucher's disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Sodium oxybate (Xyrem) for fibromyalgia - first line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Roflumilast (Daxas) for chronic obstructive pulmonary disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Adalimumab (Humira) for ulcerative colitis
2009 NIHR Horizon Scanning Centre (NIHR HSC) Abatacept (Orencia) for active rheumatoid arthritis
2009 NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Xarelto) for stroke prevention in atrial fibrillation
2009 NIHR Horizon Scanning Centre (NIHR HSC) Risperidone long-acting injection (Risperdal Consta) for prevention of recurrent episodes in bipolar 1 disorder
2009 NIHR Horizon Scanning Centre (NIHR HSC) Rilonacept for cryopyrin associated periodic syndromes
2009 NIHR Horizon Scanning Centre (NIHR HSC) Pralatrexate for peripheral T-cell lymphoma - relapsed and/or refractory
2009 NIHR Horizon Scanning Centre (NIHR HSC) Laromustine (Onrigin) for acute myeloid leukaemia in newly diagnosed elderly patients - induction therapy
2009 NIHR Horizon Scanning Centre (NIHR HSC) Dexamethasone intravitreal implant (Posurdex) for macular oedema secondary to central or branch retinal vein occlusion
2009 NIHR Horizon Scanning Centre (NIHR HSC) Colistimethate sodium powder for inhalation (Colobreathe) for pseudomonas aeruginosa lung infection in cystic fibrosis
2009 NIHR Horizon Scanning Centre (NIHR HSC) Clevidipine (Cleviprex) for acute hypertension
2009 NIHR Horizon Scanning Centre (NIHR HSC) Cediranib (Recentin) for recurrent glioblastoma multiforme - second or third line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Cediranib (Recentin) with XELOX or FOLFOX for advanced metastatic colorectal cancer - first line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Ataluren for nonsense mutation dystrophinopathy
2009 NIHR Horizon Scanning Centre (NIHR HSC) Albinterferon alfa-2b (Joulferon) for hepatitis C with compensated liver disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (VEGF-Trap) for locally advanced or metastatic non-small cell lung cancer - second line
2009 NIHR Horizon Scanning Centre (NIHR HSC) AEGR-733 (Lomitapide) for hypercholesterolaemia
2009 NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (VEGF-Trap) for metastatic colorectal cancer - second line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Cabazitaxel (XRP-6258) for hormone refractory, metastatic prostate cancer - second line after docetaxel
2009 NIHR Horizon Scanning Centre (NIHR HSC) Neurology monitoring (Entropy) for depth of anaesthesia
2009 NIHR Horizon Scanning Centre (NIHR HSC) Eplivanserin for chronic insomnia characterised by difficulties with sleep maintenance
2009 NIHR Horizon Scanning Centre (NIHR HSC) Eribulin for locally advanced or metastatic breast cancer - third line; monotherapy
2009 NIHR Horizon Scanning Centre (NIHR HSC) Indacaterol (Onbrez Breezhaler) for chronic obstructive pulmonary disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab for follicular non-Hodgkin's lymphoma - refractory
2009 NIHR Horizon Scanning Centre (NIHR HSC) Patupilone (EPO906) for recurrent epithelial ovarian cancer - refractory and/or resistant
2009 NIHR Horizon Scanning Centre (NIHR HSC) Pirfenidone for idiopathic pulmonary fibrosis
2009 NIHR Horizon Scanning Centre (NIHR HSC) Quetiapine (Seroquel XL) for major depressive disorder
2009 NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for macular oedema secondary to central or branch retinal vein occlusion
2009 NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for diabetic macular oedema
2009 NIHR Horizon Scanning Centre (NIHR HSC) Retigabine for partial onset epilepsy - refractory
2009 NIHR Horizon Scanning Centre (NIHR HSC) Sativex for adults experiencing pain from cancer
2009 NIHR Horizon Scanning Centre (NIHR HSC) Vinflunine (Javlor) for transitional cell carcinoma of the urothelial tract - second line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Afamelanotide for erythropoietic protoporphyria and congenital erythropoietic porphyria
2009 NIHR Horizon Scanning Centre (NIHR HSC) Alipogene tiparvovec (AMT-011, Glybera) for lipoprotein lipase deficiency
2009 NIHR Horizon Scanning Centre (NIHR HSC) Clopidogrel (Plavix) for neonates and infants with cyanotic congenital heart disease who have undergone a palliative shunt procedure
2009 NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab for fludarabine-refractory chronic lymphocytic leukaemia - second or third-line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Omalizumab (Xolair) for severe persistent allergic asthma in children
2009 NIHR Horizon Scanning Centre (NIHR HSC) Silodosin for benign prostatic hyperplasia
2009 NIHR Horizon Scanning Centre (NIHR HSC) WATCHMAN left atrial appendage (LAA) closure device for non-valvular atrial fibrillation (AF)
2009 NIHR Horizon Scanning Centre (NIHR HSC) Agento I.C for ventilator associated pneumonia
2009 NIHR Horizon Scanning Centre (NIHR HSC) Radachlorin photodynamic therapy for basal cell carcinoma
2009 The Swedish Council on Health Technology Assessment (SBU) [Computerized training for children with ADHD]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Age-related macular degeneration: the role of current treatment strategies]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Amotosalen (Intercept) for the inactivation of pathogens for transfusion therapy]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Angiographic profile of patients undergoing drug eluting stent implantation in Spain. Variability of off-label indications]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Artificial liver support systems]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [AUDIT ONCOrisk: Quality of the information in the study about digestive oncological surgery results]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Comparison of the effectiveness of slow-release dosage forms (depot) versus oral dosage forms of antipsychotics (typical and atypical), marketed in Catalonia, in patients with a diagnosis of schizophrenia]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Defibrillators in public places]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Development of a shared knowledge system for network assessment of technological innovation in medicine]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Eculizumab for the treatment of paroxysmal nocturnal haemoglobinuria]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Effectiveness of the filum terminale section for the treatment of Chiari I malformation]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Hadrontherapy in the treatment of cancer]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Health and health services use in immigrant and native population in Spain]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Impact of clinical and health services research in advancing knowledge. Applied study to the CAHTA research calls]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Implementation and development of a treatment programme for peritoneal carcinomatosis in Catalonia. Indications and clinical results using Sugarbaker's technique]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Influence of an existing health care plan aimed at managing ST-elevation myocardial infarction on the waiting time until re-perfusion, and types of re-perfusion. Pilot study]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Lower respiratory tract infections of a viral origin in the paediatric population: systematic review of Spanish literature]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Miglustat (Zavesca) in the treatment of Niemann-Pick type C disease]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Overweight in the teenager population: quality of life, access to health care services and cost-effectiveness of interventions]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Trabectedin (Yondelis) in the treatment of soft tissue sarcomas]
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Indirect evidence: indirect treatment comparisons in meta-analysis
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Portable ultrasonography in small emergency departments: a systematic review of the guidelines and clinical-effectiveness
2009 Adelaide Health Technology Assessment (AHTA) A toolkit for the identification and assessment of new and emerging health technologies
2009 Adelaide Health Technology Assessment (AHTA) Cervista HPV 16/18 for the identification of strains of the human papillomavirus associated with cervical cancer
2009 Adelaide Health Technology Assessment (AHTA) New and emerging technologies for breast cancer detection
2009 Adelaide Health Technology Assessment (AHTA) Rapid testing and targeted population screening for Helicobacter pylori
2009 Adelaide Health Technology Assessment (AHTA) Internet delivered cognitive behavioural therapy for patients with depression
2009 Adelaide Health Technology Assessment (AHTA) Rapid urine test for Chlamydia trachomatis
2009 Adelaide Health Technology Assessment (AHTA) Wearable artificial kidney (WAK): Portable dialysis for patients with chronic kidney disease
2009 Adelaide Health Technology Assessment (AHTA) LifePort kidney transporter: Portable donor kidney transporter/ perfuser
2009 Adelaide Health Technology Assessment (AHTA) NMP22 BladderChek Diagnostic test for bladder cancer: update
2009 Adelaide Health Technology Assessment (AHTA) TomoTherapy HI-ART System radiotherapy planning and treatment for cancer
2009 Adelaide Health Technology Assessment (AHTA) Non-invasive prenatal diagnostic test for trisomy-21 (Down's Syndrome)
2009 Adelaide Health Technology Assessment (AHTA) 0.2-0.5 Tesla MRi for the detection of arthritis and musculoskeletal disease
2009 Adelaide Health Technology Assessment (AHTA) Breast tomosynthesis: a breast cancer screening tool
2009 Adelaide Health Technology Assessment (AHTA) Narrow Band Imaging for the improved detection of precancerous lesions during colonoscopy
2009 Adelaide Health Technology Assessment (AHTA) MRI for diagnosis of rheumatoid arthritis
2009 Adelaide Health Technology Assessment (AHTA) Hypertonic saline therapy for cystic fibrosis
2009 Adelaide Health Technology Assessment (AHTA) Continuous glucose monitoring in pregnant women with diabetes
2009 Adelaide Health Technology Assessment (AHTA) LIPOchip DNA microarray for the detection of familial hypercholesterolaemia
2009 Adelaide Health Technology Assessment (AHTA) T-Stat system for the detection of tissue ischemia
2009 Andalusian Health Technology Assessment Area (AETSA) [Development of criteria, complexity indicators and management strategies on frailty]
2009 Health Intervention and Technology Assessment Program (HITAP) The Thai population based preference scores for EQ5D health states